産後うつ病治療の世界市場（～2026年）

• 英文タイトル：Global Postpartum Depression Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04334
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は産後うつ病治療のグローバル市場について調査・分析したレポートです。種類別（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、その他の抗うつ薬）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別産後うつ病治療の競争状況、市場シェア
・世界の産後うつ病治療市場：種類別市場規模 2015年-2020年（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、その他の抗うつ薬）
・世界の産後うつ病治療市場：種類別市場規模予測 2021年-2026年（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、その他の抗うつ薬）
・世界の産後うつ病治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他）
・世界の産後うつ病治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他）
・北米の産後うつ病治療市場分析：米国、カナダ
・ヨーロッパの産後うつ病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの産後うつ病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の産後うつ病治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの産後うつ病治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Allergan、Anikem Laboratories、Cipla、Eli Lilly、Intas Pharmaceutical、Marinus Pharmaceuticals、Mylan、Pfizer、SAGE Therapeutics、Sun Pharmaceuticals
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Postpartum Depression Treatment Market
The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Postpartum Depression Treatment Scope and Market Size
Postpartum Depression Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Postpartum Depression Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Allergan
Anikem Laboratories
Cipla
Eli Lilly
Intas Pharmaceutical
Marinus Pharmaceuticals
Mylan
Pfizer
SAGE Therapeutics
Sun Pharmaceuticals

Market segment by Type, the product can be split into
Selective Serotonin Reuptake Inhibitors
Serotonin Norepinephrine Reuptake Inhibitors
Other Antidepressants
Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Postpartum Depression Treatment Revenue
1.4 Market by Type
1.4.1 Global Postpartum Depression Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Selective Serotonin Reuptake Inhibitors
1.4.3 Serotonin Norepinephrine Reuptake Inhibitors
1.4.4 Other Antidepressants
1.5 Market by Application
1.5.1 Global Postpartum Depression Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Postpartum Depression Treatment Market Perspective (2015-2026)
2.2 Global Postpartum Depression Treatment Growth Trends by Regions
2.2.1 Postpartum Depression Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Postpartum Depression Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Postpartum Depression Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Postpartum Depression Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Postpartum Depression Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Postpartum Depression Treatment Players by Market Size
3.1.1 Global Top Postpartum Depression Treatment Players by Revenue (2015-2020)
3.1.2 Global Postpartum Depression Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Postpartum Depression Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Postpartum Depression Treatment Market Concentration Ratio
3.2.1 Global Postpartum Depression Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Postpartum Depression Treatment Revenue in 2019
3.3 Postpartum Depression Treatment Key Players Head office and Area Served
3.4 Key Players Postpartum Depression Treatment Product Solution and Service
3.5 Date of Enter into Postpartum Depression Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Postpartum Depression Treatment Historic Market Size by Type (2015-2020)
4.2 Global Postpartum Depression Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Postpartum Depression Treatment Market Size by Application (2015-2020)
5.2 Global Postpartum Depression Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Postpartum Depression Treatment Market Size (2015-2020)
6.2 Postpartum Depression Treatment Key Players in North America (2019-2020)
6.3 North America Postpartum Depression Treatment Market Size by Type (2015-2020)
6.4 North America Postpartum Depression Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Postpartum Depression Treatment Market Size (2015-2020)
7.2 Postpartum Depression Treatment Key Players in Europe (2019-2020)
7.3 Europe Postpartum Depression Treatment Market Size by Type (2015-2020)
7.4 Europe Postpartum Depression Treatment Market Size by Application (2015-2020)

8 China
8.1 China Postpartum Depression Treatment Market Size (2015-2020)
8.2 Postpartum Depression Treatment Key Players in China (2019-2020)
8.3 China Postpartum Depression Treatment Market Size by Type (2015-2020)
8.4 China Postpartum Depression Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Postpartum Depression Treatment Market Size (2015-2020)
9.2 Postpartum Depression Treatment Key Players in Japan (2019-2020)
9.3 Japan Postpartum Depression Treatment Market Size by Type (2015-2020)
9.4 Japan Postpartum Depression Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Postpartum Depression Treatment Market Size (2015-2020)
10.2 Postpartum Depression Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Postpartum Depression Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Postpartum Depression Treatment Market Size by Application (2015-2020)

11 India
11.1 India Postpartum Depression Treatment Market Size (2015-2020)
11.2 Postpartum Depression Treatment Key Players in India (2019-2020)
11.3 India Postpartum Depression Treatment Market Size by Type (2015-2020)
11.4 India Postpartum Depression Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Postpartum Depression Treatment Market Size (2015-2020)
12.2 Postpartum Depression Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Postpartum Depression Treatment Market Size by Type (2015-2020)
12.4 Central & South America Postpartum Depression Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Allergan
13.1.1 Allergan Company Details
13.1.2 Allergan Business Overview
13.1.3 Allergan Postpartum Depression Treatment Introduction
13.1.4 Allergan Revenue in Postpartum Depression Treatment Business (2015-2020))
13.1.5 Allergan Recent Development
13.2 Anikem Laboratories
13.2.1 Anikem Laboratories Company Details
13.2.2 Anikem Laboratories Business Overview
13.2.3 Anikem Laboratories Postpartum Depression Treatment Introduction
13.2.4 Anikem Laboratories Revenue in Postpartum Depression Treatment Business (2015-2020)
13.2.5 Anikem Laboratories Recent Development
13.3 Cipla
13.3.1 Cipla Company Details
13.3.2 Cipla Business Overview
13.3.3 Cipla Postpartum Depression Treatment Introduction
13.3.4 Cipla Revenue in Postpartum Depression Treatment Business (2015-2020)
13.3.5 Cipla Recent Development
13.4 Eli Lilly
13.4.1 Eli Lilly Company Details
13.4.2 Eli Lilly Business Overview
13.4.3 Eli Lilly Postpartum Depression Treatment Introduction
13.4.4 Eli Lilly Revenue in Postpartum Depression Treatment Business (2015-2020)
13.4.5 Eli Lilly Recent Development
13.5 Intas Pharmaceutical
13.5.1 Intas Pharmaceutical Company Details
13.5.2 Intas Pharmaceutical Business Overview
13.5.3 Intas Pharmaceutical Postpartum Depression Treatment Introduction
13.5.4 Intas Pharmaceutical Revenue in Postpartum Depression Treatment Business (2015-2020)
13.5.5 Intas Pharmaceutical Recent Development
13.6 Marinus Pharmaceuticals
13.6.1 Marinus Pharmaceuticals Company Details
13.6.2 Marinus Pharmaceuticals Business Overview
13.6.3 Marinus Pharmaceuticals Postpartum Depression Treatment Introduction
13.6.4 Marinus Pharmaceuticals Revenue in Postpartum Depression Treatment Business (2015-2020)
13.6.5 Marinus Pharmaceuticals Recent Development
13.7 Mylan
13.7.1 Mylan Company Details
13.7.2 Mylan Business Overview
13.7.3 Mylan Postpartum Depression Treatment Introduction
13.7.4 Mylan Revenue in Postpartum Depression Treatment Business (2015-2020)
13.7.5 Mylan Recent Development
13.8 Pfizer
13.8.1 Pfizer Company Details
13.8.2 Pfizer Business Overview
13.8.3 Pfizer Postpartum Depression Treatment Introduction
13.8.4 Pfizer Revenue in Postpartum Depression Treatment Business (2015-2020)
13.8.5 Pfizer Recent Development
13.9 SAGE Therapeutics
13.9.1 SAGE Therapeutics Company Details
13.9.2 SAGE Therapeutics Business Overview
13.9.3 SAGE Therapeutics Postpartum Depression Treatment Introduction
13.9.4 SAGE Therapeutics Revenue in Postpartum Depression Treatment Business (2015-2020)
13.9.5 SAGE Therapeutics Recent Development
13.10 Sun Pharmaceuticals
13.10.1 Sun Pharmaceuticals Company Details
13.10.2 Sun Pharmaceuticals Business Overview
13.10.3 Sun Pharmaceuticals Postpartum Depression Treatment Introduction
13.10.4 Sun Pharmaceuticals Revenue in Postpartum Depression Treatment Business (2015-2020)
13.10.5 Sun Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Postpartum Depression Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Postpartum Depression Treatment Revenue
Table 3. Ranking of Global Top Postpartum Depression Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Postpartum Depression Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Selective Serotonin Reuptake Inhibitors
Table 6. Key Players of Serotonin Norepinephrine Reuptake Inhibitors
Table 7. Key Players of Other Antidepressants
Table 8. Global Postpartum Depression Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Postpartum Depression Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Postpartum Depression Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Postpartum Depression Treatment Market Share by Regions (2015-2020)
Table 12. Global Postpartum Depression Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Postpartum Depression Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Postpartum Depression Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Postpartum Depression Treatment Players
Table 19. Global Postpartum Depression Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Postpartum Depression Treatment Market Share by Players (2015-2020)
Table 21. Global Top Postpartum Depression Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postpartum Depression Treatment as of 2019)
Table 22. Global Postpartum Depression Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Postpartum Depression Treatment Product Solution and Service
Table 25. Date of Enter into Postpartum Depression Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Postpartum Depression Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Postpartum Depression Treatment Market Size Share by Type (2015-2020)
Table 29. Global Postpartum Depression Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Postpartum Depression Treatment Market Size Share by Application (2015-2020)
Table 31. Global Postpartum Depression Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Postpartum Depression Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Postpartum Depression Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Postpartum Depression Treatment Market Share (2019-2020)
Table 35. North America Postpartum Depression Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Postpartum Depression Treatment Market Share by Type (2015-2020)
Table 37. North America Postpartum Depression Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Postpartum Depression Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Postpartum Depression Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Postpartum Depression Treatment Market Share (2019-2020)
Table 41. Europe Postpartum Depression Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Postpartum Depression Treatment Market Share by Type (2015-2020)
Table 43. Europe Postpartum Depression Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Postpartum Depression Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Postpartum Depression Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Postpartum Depression Treatment Market Share (2019-2020)
Table 47. China Postpartum Depression Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Postpartum Depression Treatment Market Share by Type (2015-2020)
Table 49. China Postpartum Depression Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Postpartum Depression Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Postpartum Depression Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Postpartum Depression Treatment Market Share (2019-2020)
Table 53. Japan Postpartum Depression Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Postpartum Depression Treatment Market Share by Type (2015-2020)
Table 55. Japan Postpartum Depression Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Postpartum Depression Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Postpartum Depression Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Postpartum Depression Treatment Market Share (2019-2020)
Table 59. Southeast Asia Postpartum Depression Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Postpartum Depression Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Postpartum Depression Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Postpartum Depression Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Postpartum Depression Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Postpartum Depression Treatment Market Share (2019-2020)
Table 65. India Postpartum Depression Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Postpartum Depression Treatment Market Share by Type (2015-2020)
Table 67. India Postpartum Depression Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Postpartum Depression Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Postpartum Depression Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Postpartum Depression Treatment Market Share (2019-2020)
Table 71. Central & South America Postpartum Depression Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Postpartum Depression Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Postpartum Depression Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Postpartum Depression Treatment Market Share by Application (2015-2020)
Table 75. Allergan Company Details
Table 76. Allergan Business Overview
Table 77. Allergan Product
Table 78. Allergan Revenue in Postpartum Depression Treatment Business (2015-2020) (Million US$)
Table 79. Allergan Recent Development
Table 80. Anikem Laboratories Company Details
Table 81. Anikem Laboratories Business Overview
Table 82. Anikem Laboratories Product
Table 83. Anikem Laboratories Revenue in Postpartum Depression Treatment Business (2015-2020) (Million US$)
Table 84. Anikem Laboratories Recent Development
Table 85. Cipla Company Details
Table 86. Cipla Business Overview
Table 87. Cipla Product
Table 88. Cipla Revenue in Postpartum Depression Treatment Business (2015-2020) (Million US$)
Table 89. Cipla Recent Development
Table 90. Eli Lilly Company Details
Table 91. Eli Lilly Business Overview
Table 92. Eli Lilly Product
Table 93. Eli Lilly Revenue in Postpartum Depression Treatment Business (2015-2020) (Million US$)
Table 94. Eli Lilly Recent Development
Table 95. Intas Pharmaceutical Company Details
Table 96. Intas Pharmaceutical Business Overview
Table 97. Intas Pharmaceutical Product
Table 98. Intas Pharmaceutical Revenue in Postpartum Depression Treatment Business (2015-2020) (Million US$)
Table 99. Intas Pharmaceutical Recent Development
Table 100. Marinus Pharmaceuticals Company Details
Table 101. Marinus Pharmaceuticals Business Overview
Table 102. Marinus Pharmaceuticals Product
Table 103. Marinus Pharmaceuticals Revenue in Postpartum Depression Treatment Business (2015-2020) (Million US$)
Table 104. Marinus Pharmaceuticals Recent Development
Table 105. Mylan Company Details
Table 106. Mylan Business Overview
Table 107. Mylan Product
Table 108. Mylan Revenue in Postpartum Depression Treatment Business (2015-2020) (Million US$)
Table 109. Mylan Recent Development
Table 110. Pfizer Business Overview
Table 111. Pfizer Product
Table 112. Pfizer Company Details
Table 113. Pfizer Revenue in Postpartum Depression Treatment Business (2015-2020) (Million US$)
Table 114. Pfizer Recent Development
Table 115. SAGE Therapeutics Company Details
Table 116. SAGE Therapeutics Business Overview
Table 117. SAGE Therapeutics Product
Table 118. SAGE Therapeutics Revenue in Postpartum Depression Treatment Business (2015-2020) (Million US$)
Table 119. SAGE Therapeutics Recent Development
Table 120. Sun Pharmaceuticals Company Details
Table 121. Sun Pharmaceuticals Business Overview
Table 122. Sun Pharmaceuticals Product
Table 123. Sun Pharmaceuticals Revenue in Postpartum Depression Treatment Business (2015-2020) (Million US$)
Table 124. Sun Pharmaceuticals Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postpartum Depression Treatment Market Share by Type: 2020 VS 2026
Figure 2. Selective Serotonin Reuptake Inhibitors Features
Figure 3. Serotonin Norepinephrine Reuptake Inhibitors Features
Figure 4. Other Antidepressants Features
Figure 5. Global Postpartum Depression Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Postpartum Depression Treatment Report Years Considered
Figure 10. Global Postpartum Depression Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Postpartum Depression Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Postpartum Depression Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Postpartum Depression Treatment Market Share by Players in 2019
Figure 15. Global Top Postpartum Depression Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postpartum Depression Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Postpartum Depression Treatment Revenue in 2019
Figure 17. North America Postpartum Depression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Postpartum Depression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Postpartum Depression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Postpartum Depression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Postpartum Depression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Postpartum Depression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Postpartum Depression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介

産後うつ病治療薬の世界市場（～2026年）

Global Postpartum Depression Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04333 2020年11月20日 97Pages
当調査資料は産後うつ病治療薬のグローバル市場について調査・分析したレポートです。種類別（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、三環系抗うつ薬、モノアミン酸化酵素阻害薬）市場規模、用途別（病院薬局、オンライン薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、...

うつ病治療療法の世界市場（～2026年）

Global Depression Treatment Therapy Market Size, Status and Forecast 2020-2026
MRC2-11QY11618 2020年11月25日 125Pages
当調査資料はうつ病治療療法のグローバル市場について調査・分析したレポートです。種類別（医薬品、治療装置）市場規模、用途別（季節性情動障害（SAD）、大うつ病、気分変調性障害、産後うつ病、非定型うつ病、精神病性うつ病、双極性障害）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

不安障害・うつ病治療の世界市場（～2026年）

Global Anxiety Disorders And Depression Treatment Market Insights and Forecast to 2026
MRC2-11QY02616 2020年11月20日 111Pages
当調査資料は不安障害・うつ病治療のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬、治療・装置）市場規模、用途別（病院用、診療所用、家庭用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

脂質異常症治療の世界市場（～2026年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12520 2020年11月25日 92Pages
当調査資料は脂質異常症治療のグローバル市場について調査・分析したレポートです。種類別（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他薬剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

水疱性類天疱瘡治療の世界市場（～2026年）

Global Bullous Pemphigoid Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11210 2020年11月25日 91Pages
当調査資料は水疱性類天疱瘡治療のグローバル市場について調査・分析したレポートです。種類別（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬）市場規模、用途別（病院薬局、小売薬局、通信販売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本...

ナルコレプシー治療の世界市場（～2026年）

Global Narcolepsy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03907 2020年11月20日 94Pages
当調査資料はナルコレプシー治療のグローバル市場について調査・分析したレポートです。種類別（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他）市場規模、用途別（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー）市場規模、...

ジフテリア治療の世界市場（～2026年）

Global Diphtheria Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11675 2020年11月25日 97Pages
当調査資料はジフテリア治療のグローバル市場について調査・分析したレポートです。種類別（破傷風免疫グロブリン、破傷風トキソイド、破傷風-ジフテリア、ジフテリアトキソイド、百日咳）市場規模、用途別（抗毒素、抗生物質、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イ...

ハンセン病治療の世界市場（～2026年）

Global Leprosy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12500 2020年11月25日 93Pages
当調査資料はハンセン病治療のグローバル市場について調査・分析したレポートです。種類別（スルホン、フェナジン誘導体、抗管状薬、その他）市場規模、用途別（病院、クリニック、薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

消化器疾患治療　の世界市場（～2026年）

Global Digestive Distress Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11647 2020年11月25日 96Pages
当調査資料は消化器疾患治療　のグローバル市場について調査・分析したレポートです。種類別（上部消化管、下部消化管）市場規模、用途別（病院薬局、オンライン薬局、ドラッグストア、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

軟骨肉腫治療の世界市場（～2026年）

Global Chondrosarcoma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11355 2020年11月25日 96Pages
当調査資料は軟骨肉腫治療のグローバル市場について調査・分析したレポートです。種類別（外科的治療、化学療法、放射線療法）市場規模、用途別（病院、専門クリニック、がん治療センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

産後うつ病治療薬の世界市場（～2026年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
うつ病治療療法の世界市場（～2026年） Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the …
不安障害・うつ病治療の世界市場（～2026年） Anxiety disorders and depression are treatable, and the vast majority of people can be helped with professional care. Often depression and an anxiety disorder can be treated similarly. In many cases, therapy can be tailored to an individual so that it works to reduce the symptoms of both disorders. …
慢性うつ病性人格障害治療の世界市場（～2026年） Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of …
うつ病性障害の世界市場（～2026年） Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including…